PHARMAC seeks clinical feedback on its cost-utility analysis methodology
N Z Med J
.
2006 Aug 4;119(1239):U2113.
Authors
Rachel Grocott
,
Peter Moodie
PMID:
16912730
No abstract available
Publication types
Letter
MeSH terms
Cost-Benefit Analysis / methods
Drug and Narcotic Control*
Economics, Pharmaceutical*
Humans
New Zealand